CME Group (NASDAQ:CME) Trading Up 7.4% After Strong Earnings

CME Group Inc. (NASDAQ:CME)’s stock price traded up 7.4% during trading on Wednesday following a stronger than expected earnings report. The company traded as high as $254.02 and last traded at $254.9870. Approximately 465,151 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 2,750,870 shares. The stock had previously closed at $237.38.

The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business posted $2.96 EPS. CME Group’s revenue was up .8% on a year-over-year basis.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group posted Q2 adjusted earnings of $2.99 per share, topping estimates, while revenue of about $1.71 billion also beat forecasts. The upside was supported by strong hedging demand and active derivatives trading, which reinforced confidence in the company’s core exchange business. Reuters article
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, suggesting momentum remains solid heading into the rest of the year. Quiver Quantitative article
• Positive Sentiment: Trading volumes were strong, with average daily volume near 29.8 million contracts and record market data revenue of $238 million, both of which support the view that CME is benefiting from elevated market activity and pricing power. Seeking Alpha presentation
• Positive Sentiment: Shares also gained support from unusual call-option buying and broader investor interest following the earnings beat, which can reinforce near-term upward momentum. Quiver Quantitative options flow article
• Neutral Sentiment: CEO Terrence Duffy pushed back on market chatter about potential perpetual-futures products, saying clients are not demanding them. That appears to have been a side issue rather than a direct driver of the move. Bloomberg article

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. TD Cowen decreased their price objective on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and upped their target price for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Piper Sandler reduced their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a research note on Thursday, June 18th. Finally, Erste Group Bank downgraded CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $292.12.

Insider Transactions at CME Group

In related news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CME. Lederer & Associates Investment Counsel CA lifted its holdings in shares of CME Group by 13.1% during the second quarter. Lederer & Associates Investment Counsel CA now owns 5,424 shares of the financial services provider’s stock worth $1,198,000 after purchasing an additional 627 shares during the period. Handelsbanken Fonder AB increased its holdings in CME Group by 0.7% in the 2nd quarter. Handelsbanken Fonder AB now owns 129,709 shares of the financial services provider’s stock worth $28,644,000 after buying an additional 915 shares during the period. Perkins Coie Trust Co raised its position in CME Group by 9.0% during the 2nd quarter. Perkins Coie Trust Co now owns 2,613 shares of the financial services provider’s stock worth $577,000 after buying an additional 215 shares during the last quarter. Financial Management Professionals Inc. raised its position in CME Group by 24.7% during the 2nd quarter. Financial Management Professionals Inc. now owns 2,053 shares of the financial services provider’s stock worth $453,000 after buying an additional 406 shares during the last quarter. Finally, Harrell Investment Partners LLC lifted its stake in CME Group by 2.5% during the 2nd quarter. Harrell Investment Partners LLC now owns 26,479 shares of the financial services provider’s stock valued at $5,847,000 after acquiring an additional 653 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Price Performance

The firm has a market capitalization of $90.31 billion, a PE ratio of 21.27, a P/E/G ratio of 2.95 and a beta of 0.25. The firm’s fifty day moving average price is $255.87 and its 200 day moving average price is $281.51. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.